RDI · Samples · Cohort
We collect samples from Alzheimer's disease patients.
CSF and plasma from patients across the Alzheimer's continuum — preclinical through moderate dementia, with linked amyloid and tau biomarker status. We design the collection against your assay's clinical claims and regulatory pathway.
Analytes commonly measured in this cohort
p-Tau 217Amyloid-β 42
Need Alzheimer's disease samples for a study?
Tell us your assay and intended use. We'll send the full collection plan within two business days.